DEALTALK-U.S. companies skeptical of corporate China's advances

April 27 (Reuters) - Chinese life sciences entrepreneur Wei

Zhou submitted a $1.5 billion bid for U.S. gene testing company

Affymetrix last month - topping a $1.3 billion agreed

acquisition by Thermo...

Read more